DAPAgliflozin Sodium Water glucosE EffecTs in Patients at High Cardiovascular Risk
Clinical trial NCT04258371 · UNKNOWN
Trial details
- NCT number
- NCT04258371
- Sponsor
- University Health Network, Toronto
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-10
- Primary completion
- 2023-12-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.